Skip to content
WeighLab

Ivy Rx vs ReadyRx

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Ivy Rx

Provider comparison

Patients comparing a low advertised compounded starting price who will check the exact molecule, plan total and renewal terms.

Semaglutide / month
$77/moFrom (standard shared GLP-1 injection headline, compounded; confirm selected plan)
Tirzepatide / month
Not separately disclosed (shared compounded GLP-1 headline from $77/mo)
Index 76/100 · Grade CChecked October 2026

ReadyRx

Provider comparison

Patients comparing the actual renewal cost of monthly and quarterly plans with care and shipping included.

Semaglutide / month
$249/moStanding one-month compounded plan; $229 first month with current public offer
Tirzepatide / month
$315/moStanding one-month compounded plan; $295 first month with current public offer
Index 76/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 76/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Ivy Rx
Not published; confirm eligibility
ReadyRx
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Ivy Rx

ReadyRx

Semaglutide / month
Ivy Rx: $77/moFrom (standard shared GLP-1 injection headline, compounded; confirm selected plan)
ReadyRx: $249/moStanding one-month compounded plan; $229 first month with current public offer
Tirzepatide / month
Ivy Rx: Not separately disclosed (shared compounded GLP-1 headline from $77/mo)
ReadyRx: $315/moStanding one-month compounded plan; $295 first month with current public offer
Semaglutide / year (modeled)
Ivy Rx: $924
ReadyRx: $2,988
Tirzepatide / year (modeled)
Ivy Rx: —
ReadyRx: $3,780
State availability
Ivy Rx: Not published; confirm eligibility
ReadyRx: All 50 states
Oral / sublingual option listed
Ivy Rx: Not listed
ReadyRx: Not listed
Brand-name access listed
Ivy Rx: Yes
ReadyRx: Yes
Provider facts checked
Ivy Rx: October 2026
ReadyRx: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Ivy Rx

Patients comparing a low advertised compounded starting price who will check the exact molecule, plan total and renewal terms.

Reasons to consider it

  • Publishes a $77 standard injection headline and separate $69 microdose option
  • Says the injection price stays the same at every dose
  • Includes same-day physician review and free delivery

What to weigh up

  • The shared starting headline does not establish a separate public tirzepatide price
  • No full state list or individual dispensing pharmacy is published
  • Terms describe one- or three-month initial plans followed by monthly automatic renewal

ReadyRx

Patients comparing the actual renewal cost of monthly and quarterly plans with care and shipping included.

Reasons to consider it

  • Current one-month renewal rates are $249 semaglutide and $315 tirzepatide
  • The public price calculator separates first-month discounts from renewal prices
  • Provider messaging, shipping, protocols, meal plans and coaching are included

What to weigh up

  • Headline first-month offers are lower than the recurring price
  • The lower $179 semaglutide first-month offer is calculated for the quarterly plan
  • Cancel at least four business days before renewal; shipments can be processed early

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Ivy RxReadyRx
Normalized Cost/Month
Ivy Rx:
97/100
ReadyRx:
61/100
Price Transparency
Ivy Rx:
94/100
ReadyRx:
94/100
Nationwide Access
Ivy Rx:
24/100
ReadyRx:
86/100
Formulation Options
Ivy Rx:
66/100
ReadyRx:
79/100
Clinical Oversight
Ivy Rx:
82/100
ReadyRx:
79/100
Contract Flexibility
Ivy Rx:
85/100
ReadyRx:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.